Facebook: World Allergy Organization
Twitter: World Allergy Organization
LinkedIn: World Allergy Organization
Instagram: World Allergy Organization

Prof. Francesca Levi-Schaffer, PharmD, PhD

Francesca Levi-Schaffer is a member of the Board of Directors of the World Allergy Organization (WAO). She is a Professor at The Hebrew University of Jerusalem in the Institute for Drug Research of the School of Pharmacy. She holds the Isaac and Myrna Kaye Chair in Immunopharmacology. Prof. Levi-Schaffer was Chairperson of the Department of Pharmacology and Experimental Therapeutics and head of its Teaching Unit (2006-2009). She is an honorary senior lecturer at the National Heart and Lung Institute of the Imperial College (London). Prof. Levi-Schaffer was born in Italy and completed her PharmD degree at the University of Milano. In 1984 she received her PhD degree in Immunology from the Weizmann Institute, Rehovot, Israel. Her post-doctoral training was at Harvard Medical School (1984-86).

Prof. Levi-Schaffer has published 148 articles in peer-reviewed journals, 62 reviews and editorials and 16 book chapters. She has one patent and two provisional patents pending. Since 2011, she has served as Chairperson of the National Committee of the International Union of Pharmacology (IUPHAR) representing the Israel Academy of Sciences and Humanities. In 2012, she was instrumental in the establishment of an Immunopharmacology Section in the IUPHAR and serves as its Chairperson. She is a member of the Executive Committee of the International Eosinophil Society, the Israeli Ministry of Health Committee for Human Experimentation of New Drugs, the Management Committee of EU COST Action BM1007 (Mast Cells and Basophils – Targets for Innovative Therapies), the Editorial Board of BMC Immunology, and is Vice-President of the European Mast Cell and Basophil Research Network.

Prof. Levi-Schaffer's expertise is in the area of immunopharmacology of allergy focusing on mast cell and eosinophil cross-talk and on these cells' inhibitory and activating receptors; mastocytosis treatment; autism and allergy; atopic dermatitis; bispecific antibodies as novel drugs for allergy.